NuvaRing Birth Control Device Linked with Blood Clots
The NuvaRing is the latest contraceptive under fire as a result of reports linking it with blood clots. Manufactured by Organon USA, the NuvaRing is a type of hormonal contraceptive developed as an alternative to oral contraceptives and the birth control patch.
NuvaRing was approved for use by the Food and Drug Administration in 2001. The contraceptive is a vaginal ring designed to release progesterone and estrogen over a three-week period to prevent pregnancy. After three weeks, the NuvaRing can be removed for one week, before starting the process over again.
Organon USA was purchased by multinational pharmaceutical company Schering Plough in November of 2007. In addition to gaining the rights to all Organon USA products, Schering Plough also assumed any associated liabilities.
NuvaRing Stroke Injury
A wrongful death lawsuit has been filed on behalf of a New Jersey woman who died suddenly after starting to use the NuvaRing. The lawsuit was filed by her husband who claims that she died “overnight” as a result of a blood clot that he believes was brought on by the NuvaRing.
The lawsuit, which also names Schering Plough, is just one of many that have been filed against the manufacturers of the NuvaRing. As a hormonal contraceptive, the NuvaRing poses certain risks, including blood clots, stroke, heart attack and breast cancer. There has even been a lawsuit filed against NuvaRing on the basis that it caused toxic shock syndrome, a bacterial condition that has been linked with the prolonged use of tampons.
NuvaRing representatives have refused to accept responsibility for any wrongdoing associated with the safety of their product, claiming that the NuvaRing poses no more risks than other hormonal contraceptives.
Hormonal Contraceptives and the Blood Clot Connection
NuvaRing is the latest hormonal contraceptive to be targeted by personal injury litigation. Ortho Evra, the hormonal contraceptive patch, has also been a recent target as women using it experienced an increased risk of blood clotting and stroke. Blood clotting, or venous thrombosis, has long been associated with hormonal contraceptives. In many cases, the risks are minimal, though some of the newer hormonal contraceptives have been targeted because of an increased risk factor.
The FDA has been petitioned on behalf of more than 100,000 consumers throughout the United States to recall and ban the use of third generation oral contraceptives that contain the deogestrel molecule linked with blood clots.
If you or a loved one has been injured as a result of using the NuvaRing contraceptive, you may be entitled to compensation. Drug manufacturers are responsible for ensuring the safety and efficacy of their products. Failure to adequately do so or failure to inform patients and doctors of any newfound side effects or risk factors associated with a product is viewed as negligent and grounds for pharmaceutical litigation.
The Pensacola personal injury attorneys of Aylstock, Witkin Kreis & Overholtz handle national litigation across the United States for victims injured by defective pharmaceuticals and medical devices. AWKO Law is dedicated to protecting your rights. Contact AWKO Law at (844) 794-7402 to get information about your rights as a NuvaRing victim.